Harper Malone relapsed in March, six months after her last chemo ended. The only thing left that could put her back into remission was a targeted infusion her oncology team had used for years, FDA-approved, standard of care. Her mother, Carrie, called me the morning the second denial came in.
“Dr. Grant,” she said, “they said no again. What do we do now?”
I’ve spent seventeen years telling parents worse things than this. I told her I’d handle it.
I filed the appeal myself. Attached the trial data, the treatment guidelines, a letter from three other oncologists at Ridgeview. I figured someone on their end would actually read it.
The third denial came back in nine hours.
Nine hours, for a case file with four hundred pages.
The letter listed a reviewing physician, Dr. R. Kessler, board certified. I looked him up out of habit before the next call, mostly so I’d know who I was arguing with.
Kessler’s license was for dermatology. Retired since 2019.
I told myself it was a clerical mix-up. Insurance paperwork is a mess. But that night I couldn’t stop thinking about a retired skin doctor’s name attached to a decision about a kid’s bone marrow.
The next morning I pulled denial letters for three other patients on my unit with the same drug and diagnosis. Same reviewer name. Same nine-hour turnaround. Same paragraph, word for word, down to a typo in “clinically indicated.”
I started keeping a folder.
A billing coordinator at Ridgeview named Denise, twenty years in claims, told me something I didn’t want to hear. This insurer had a utilization target tied to plan renewals, and Harper’s plan renewed in nine days.
Nine days was also, roughly, what Harper had left without the infusion.
I requested an in-person peer review, not another phone call. I wanted to sit across from whoever was actually making this decision.
They gave me a Thursday, at their regional office, with a medical director named Paul Ostrander and two case managers.
I brought the folder. Twelve denials. One dermatologist. One license search showing Kessler had never held pediatric privileges anywhere.
I laid it on the table and asked Ostrander how a retired dermatologist reviewed the marrow biology of a seven-year-old.
He said the name was “administrative.” That reviews were run through “the clinical algorithm system.” That Kessler’s credentials got auto-attached to cases in his old specialty pool.
I asked him to say that part again.
THE ALGORITHM PICKED THE DOCTOR’S NAME. NO HUMAN HAD READ HARPER’S CHART AT ALL.
I went completely still.
One of the case managers stopped typing. Ostrander reached for his water glass and didn’t pick it up.
“I have one more thing,” I said, and pulled a second folder out of my bag. “This copy already went to the state insurance commissioner this morning.”
Ostrander looked at the door before he looked at me.
“Before you send anything else,” he said, “there’s something about this case you don’t know yet.”
The Name Nobody Bothered to Remove
He didn’t say it right away.
He pulled his chair closer to the table, which I’d come to learn later meant he was about to say something he’d get in trouble for.
“Kessler didn’t retire in 2019,” he said. “He died in 2019.”
I heard the word and my brain did the thing where it just refuses the sentence for a second, makes you ask the question you already understood.
“Died.”
“Cardiac event. February. He was seventy-one.” Ostrander’s voice had gone flat, the tone people use when they’ve rehearsed telling the truth so many times in their head that saying it out loud feels like reading a script. “His NPI number was never deactivated in the review software. It’s been sitting in a specialty pool for skin conditions since he retired from practice in 2011. When the algorithm needs a board-certified physician to attach to an oncology denial and none of the actual on-staff oncology reviewers have bandwidth, it pulls from an overflow list. Kessler’s name has been on that overflow list for eight years.”
“So it’s been signing denials,” I said, “for three years, on a dead man’s license.”
“Not just his.” Ostrander said it fast, like getting it out was the only way it would come out at all. “There are four others in the system the same way. Retirees. One deceased, three just never removed from credentialing.”
The room had a clock on the wall, one of those cheap office ones with a red second hand that jerks instead of sweeps. I watched it move six times before I said anything else.
“How many claims,” I asked, “went through Kessler’s name after he died.”
Terri, the case manager who’d stopped typing, looked at her laptop like it might answer for her. Ostrander answered instead.
“I don’t have that number.”
“Get it.”
“I can’t get it in this room.”
What the Coordinator Already Knew
I called Denise from the parking lot before I even got in my car. Told her what Ostrander said. She was quiet for a second, then let out a breath that wasn’t surprise, it was recognition.
“I flagged that name in 2021,” she said. “Sent it up through provider relations. Somebody wrote back and said the license was still active in the system, no action needed.”
“Active meaning what. Active meaning nobody checked the guy was in the ground.”
“Active meaning the box that says active hadn’t been unchecked.” Denise has a way of saying the ugliest sentences in the flattest voice, twenty years of claims work does that to a person. “I got told it wasn’t my department. I got told a lot of things weren’t my department that year.”
I asked her why she hadn’t told me sooner.
“Because you didn’t have a folder yet,” she said. “You do now.”
I sat in my car in that parking lot for eleven minutes without turning the key. Harper had nine days left on the clock the plan renewal put on her, and I had just found out the man denying her drug had been buried for three years. I thought about calling Carrie right then and decided against it. She didn’t need the dead-dermatologist detail yet. She needed a yes.
The Call That Came Before Mine
I got the yes at 6:40 the next morning, before I’d even finished my coffee.
Not from Ostrander. From the state insurance commissioner’s office, a woman named Gail Sutter who I’d emailed the folder to at 11 p.m. two nights earlier and honestly did not expect to hear back from before Christmas. Government offices move like glaciers, usually. This one moved like the building was on fire.
“We’re opening an inquiry into your carrier’s utilization review practices,” she said. “Given the timeline you’re working with, we’ve also requested an emergency expedited authorization on the patient’s behalf. You should see something on that within the hour.”
Something came within forty minutes. Not a letter this time. A phone call from the insurer’s own case management line, a different voice than any I’d talked to, informing me that Harper Malone’s infusion was authorized, effective immediately, no further documentation required.
Twelve days of denials. Forty minutes, once a state office got involved.
I called Carrie standing in the hallway outside Harper’s room, and I could hear Harper in the background asking her mom who was on the phone, and Carrie couldn’t get words out for a second, just made a sound.
“Say it again,” she finally said to me. “Say it slow, I want to hear it right.”
“It’s approved. She starts tomorrow.”
Watching the Drip Instead of the Clock
Harper got her first dose on a Friday. She wore a unicorn on her IV pole, a stuffed one Carrie had zip-tied to the pole itself so it couldn’t fall, and she named it Dr. Kessler as a joke that made Carrie laugh in a way that scared me a little, the kind of laugh that’s mostly just relief with nowhere else to go.
I didn’t correct the joke. I let the kid have it.
I sat with them for twenty minutes of the infusion, longer than I usually stay for any one patient, because I wanted to watch the bag actually empty into her arm instead of reading about the fight in an email chain. Harper asked me if the medicine tasted like anything. I told her no, it doesn’t have a taste, it just goes to work. She said that was boring and asked if she could have a popsicle instead, and I said the popsicle could happen after.
Ostrander called me two weeks later. Not about Harper. About himself.
“I wanted you to know I put in for a transfer,” he said. “Out of medical review, into compliance. I told them either I fix the credentialing gap or I quit and tell a reporter about it instead.”
I asked if fixing it meant Kessler’s name was finally gone from the system.
“His and the other three,” Ostrander said. “It’s done. For what it’s worth.”
I didn’t tell him what it was worth. I wasn’t sure yet.
The Folder I Still Haven’t Closed
The commissioner’s inquiry is still open. Denise tells me there’s a subpoena for three years of claims run through the overflow specialty pool, and that the number, when it finally comes, is going to be in the thousands, not the dozens. Other hospitals, other kids, other parents who called their own version of me at seven in the morning asking what to do now.
I keep the folder in my bottom desk drawer, the twelve denials and the license printout and Kessler’s obituary from a Tuscaloosa newspaper, February 2019, survived by a wife and two grandchildren, donations in lieu of flowers to the American Heart Association.
Harper’s in remission. Second scan came back clean six weeks ago. She still has the unicorn, though she retired the name once she found out what it meant, which tells you she’s smarter than half the adults in that regional office.
I still don’t know how many other files have a dead man’s signature on them right now, today, denying somebody’s kid the one thing that might work. I know it’s more than twelve.
That’s the number I can’t put down.
If you’ve ever fought an insurance denial and won, or lost, I want to hear which one. Tell me in the comments.
If you’re still reeling from this outrageous tale, you might be interested in another story about a child’s unsettling experience: My Daughter Refused to Get Out of the Car at Her Uncle’s House Again. Or, for a different kind of shocking discovery, check out I Found Seven Photos of a Girl Who Shares My Birthmark, Hidden in My Boyfriend’s Closet.
